MedPath

Comparison of the Radiofrequency Treatments for the Treatment of Trigeminal Neuralgia.

Not Applicable
Completed
Conditions
Trigeminal Neuralgia
Interventions
Procedure: radiofrequency of the peripheral trigeminal branches
Procedure: radiofrequency of gasserian ganglion
Registration Number
NCT05516888
Lead Sponsor
Diskapi Teaching and Research Hospital
Brief Summary

The aim of this study is to compare the efficacy of radiofrequency of the Gasserian ganglion versus peripheral branches of the trigeminal nerve for the treatment of trigeminal neuralgia.

Detailed Description

Trigeminal neuralgia (TN) is defined as sudden, severe, short-term, stabbing and recurrent pain in the distribution of one or more branches of the trigeminal nerve. Many invasive treatments are available for patients who respond poorly to medical therapy. Among them, radiofrequency therapy is a viable option with a reliable initial and long-term clinical efficacy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
60
Inclusion Criteria
  • Diagnosed with Primary Trigeminal Neuralgia meets the criteria of the International Classification of Headache Disorders.
  • Suffering from severe trigeminal neuralgia that cannot be alleviated effectively with conservative therapy.
  • Agree to participate in the study
Exclusion Criteria
  • Infection at the puncture site.
  • Coagulation disorder.
  • Abnormal blood test (hepatic or renal function)
  • History of receiving invasive treatment (glycerol rhizolysis, radiofrequency thermocoagulation, balloon compression, gamma knife treatment, microvascular decompression)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Radiofrequency of peripheral branches of the trigeminal nerveradiofrequency of the peripheral trigeminal branchespulsed radiofrequency treatment of the peripheral branches of the trigeminal nerve
Radiofrequency of gasserian ganglionradiofrequency of gasserian ganglionradiofrequency ablation of the gasserian ganglion
Primary Outcome Measures
NameTimeMethod
The modified Barrow Neurological Institute Pain Intensity Scoresix months

The efficacy of the treatment will be assessed using the modified Barrow Neurological Institute Pain Intensity Score (I: No pain, off medications; II: Occasional pain, off medications; IIIa: No pain, continued use of medications; IIIb: Pain persists, but adequately controlled with medications; IV: Pain not adequately controlled with medications; V: No relief).

Secondary Outcome Measures
NameTimeMethod
Patient satisfactionsix months

Patient satisfaction scores on the 5-point Likert scale (1: poor, 2: fair, 3: good, 4: very good, 5: excellent)

Numeric rating scalebaseline to six months

Pain will evaluated by a numerical rating scale (0 indicates no pain, 10 indicates the most severe pain imaginable).

Trial Locations

Locations (1)

Diskapi Yildirim Beyazit Training and Research Hospital

🇹🇷

Ankara, Turkey

© Copyright 2025. All Rights Reserved by MedPath